These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 11366278)

  • 1. 3TC recommended for hepatitis B.
    Body Posit; 1999 Apr; 12(4):39. PubMed ID: 11366278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDA panel backs Glaxo Wellcome drug for use in treating chronic hepatitis B. Food and Drug Administration.
    Newsline People AIDS Coalit N Y; 1998; ():32. PubMed ID: 11367504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3TC receives full approval.
    Grodeck B; Vazquez E
    Posit Aware; 1997; 8(3):11. PubMed ID: 11364417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3TC approved for children.
    Highleyman L
    BETA; 1999 Apr; 12(2):5. PubMed ID: 11366698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Food and Drug Administration approves lamivudine for hepatitis B.
    Front Med Biol Eng; 1999; 9(1):95. PubMed ID: 10354913
    [No Abstract]   [Full Text] [Related]  

  • 6. 3TC approval may revive AZT's appeal.
    Vazquez E
    Posit Aware; 1996; 7(1):8-9. PubMed ID: 11363136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lamivudine (3TC) approved for combination use with AZT.
    James JS
    AIDS Treat News; 1995 Dec; (no 236):1-5. PubMed ID: 11363049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of long-term lamivudine in chronic hepatitis B virus-infected children.
    Ozgenç F; Arikan C; Sertoz RY; Nart D; Aydogdu S; Yagci RV
    Antivir Ther; 2004 Oct; 9(5):729-32. PubMed ID: 15535410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDA notifications. Combination lamivudine and tenofovir tablet approved.
    AIDS Alert; 2010 Jan; 25(1):10. PubMed ID: 20140989
    [No Abstract]   [Full Text] [Related]  

  • 10. Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy.
    Matthews GV; Bartholomeusz A; Locarnini S; Ayres A; Sasaduesz J; Seaberg E; Cooper DA; Lewin S; Dore GJ; Thio CL
    AIDS; 2006 Apr; 20(6):863-70. PubMed ID: 16549970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDA notifications. FDA grants approval of generic lamivudine tablets.
    AIDS Alert; 2009 Dec; 24(12):142-3. PubMed ID: 20063478
    [No Abstract]   [Full Text] [Related]  

  • 12. Occurrence and clinical outcome of lamivudine-resistant hepatitis B infection after liver transplantation.
    Seehofer D; Rayes N; Steinmüller T; Müller AR; Settmacher U; Neuhaus R; Radke C; Berg T; Hopf U; Neuhaus P
    Liver Transpl; 2001 Nov; 7(11):976-82. PubMed ID: 11699034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDA notifications. FDA approval for generic lamivudine/zidovudine.
    AIDS Alert; 2008 Jan; 23(1):12. PubMed ID: 18572476
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA notifications. Lamivudine/zidovudine combination approved for pediatric use.
    AIDS Alert; 2009 Sep; 24(9):105. PubMed ID: 19938311
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical impact and efficacy of lamivudine therapy in de novo hepatitis B infection after liver transplantation.
    Castells L; Vargas V; Rodríguez F; Allende H; Buti M; Sánchez-Avila JF; Jardí R; Margarit C; Pumarola T; Esteban R; Guardia J
    Liver Transpl; 2002 Oct; 8(10):892-900. PubMed ID: 12360430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDA notifications. Generic lamivudine tentatively approved.
    AIDS Alert; 2005 Dec; 20(12):142. PubMed ID: 16400721
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatitis B, lamivudine, and HIV.
    Kuchimanchi U; Rooney G
    BMJ; 2001 Jul; 323(7303):51. PubMed ID: 11464832
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatitis B virus prevention strategies for antibody to hepatitis B core antigen-positive liver donation: a survey of North American, European, and Asian-Pacific transplant programs.
    Perrillo R
    Liver Transpl; 2009 Feb; 15(2):223-32. PubMed ID: 19177436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDA notifications. Tentative approval for lamivudine.
    AIDS Alert; 2009 Aug; 24(8):93-4. PubMed ID: 19708084
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA notifications. FDA approves generic lamivudine.
    AIDS Alert; 2008 Dec; 23(12):142. PubMed ID: 19110688
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.